{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T05:23:43Z","timestamp":1787289823771,"version":"build-2736575974"},"reference-count":173,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010621","name":"Medical University of Lublin","doi-asserted-by":"crossref","award":["DS\/475\/26"],"award-info":[{"award-number":["DS\/475\/26"]}],"id":[{"id":"10.13039\/501100010621","id-type":"DOI","asserted-by":"crossref"}]},{"award":["DS\/475\/26"],"award-info":[{"award-number":["DS\/475\/26"]}],"id":[{"id":"https:\/\/ror.org\/016f61126","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr. Issues Mol. Biol.","CIMB"],"abstract":"<jats:p>Epilptogenesis is a long-term process that involves the transformation of a healthy brain into a seizure-producing brain. Since approximately 30% of epilepsy patients suffer from drug-resistant seizures, the concept of inhibiting the epileptogenesis process and thus preventing seizures has emerged. The search for effective methods of inhibiting epileptogenesis is possible thanks to animal models, which include kindled seizures; models based on the induction of status epilepticus resulting in subsequent spontaneous recurrent seizures, or brain trauma; and genetic models. Blood\u2013brain barrier dysfunction, inflammatory processes in the brain, and oxidative stress appear to play a major role in epileptogenesis. This prompted testing of a number of anti-inflammatory agents and antioxidants in the epileptogenic process. One noteworthy finding was that losartan (an antihypertensive drug), as a TGF-\u03b2 antagonist, proved effective in inhibiting epileptogenesis due to blood\u2013brain barrier damage. Due to the many mechanisms involved in the process of epileptogenesis, it seems that the use of a combination of drugs will be an effective method of inhibiting it. The most promising combination includes levetiracetam (a second-generation antiseizure drug), atorvastatin, and ceftriaxone (a beta-lactam antibiotic), which effectively inhibits spontaneous seizures in animals experiencing status epilepticus. Any clinical trials on the inhibition of epileptogenesis must take into account the fact that a small percentage of patients develop epileptic seizures after stroke or brain injury. Recently suggested markers predicting a high probability of epileptic seizures after brain damage may facilitate appropriate patient selection for studies on inhibition of epileptogenesis.<\/jats:p>","DOI":"10.3390\/cimb48080842","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T11:04:12Z","timestamp":1787137452000},"page":"842","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Selected Molecular Targets for Counteracting Epileptogenesis: What Do We Know About Its Effective Inhibition?"],"prefix":"10.3390","volume":"48","author":[{"given":"Krzysztof","family":"\u0141ukawski","sequence":"first","affiliation":[{"name":"Department of Physiopathology, Institute of Rural Health, 20-090 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanis\u0142aw J.","family":"Czuczwar","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, Medical University of Lublin, 20-090 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Miziak","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, Medical University of Lublin, 20-090 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0140-6736(14)60456-6","article-title":"Epilepsy: New advances","volume":"385","author":"Perucca","year":"2015","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"a022822","DOI":"10.1101\/cshperspect.a022822","article-title":"Epileptogenesis","volume":"5","author":"Lukasiuk","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.5698\/1535-7597-16.1.31","article-title":"Epileptogenesis: More Than Just the Latent Period","volume":"16","author":"Maguire","year":"2016","journal-title":"Epilepsy Curr."},{"key":"ref_4","unstructured":"Noebels, J.L., Avoli, M., Rogawski, M.A., Vezzani, A., and Delgado-Escueta, A.V. (2026, August 14). Section 3. Epileptogenesis: Molecular Mechanism and Treatments, Jasper\u2019s Basic Mechanisms of the Epilepsies, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK609842\/."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.neulet.2011.03.010","article-title":"Human clinical trials in antiepileptogenesis","volume":"497","author":"Mani","year":"2011","journal-title":"Neurosci. Lett."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1124\/pr.110.003046","article-title":"Prevention or modification of epileptogenesis after brain insults: Experimental approaches and translational research","volume":"62","author":"Brandt","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S1474-4422(10)70310-0","article-title":"Mechanisms of epileptogenesis and potential treatment targets","volume":"10","author":"Lukasiuk","year":"2011","journal-title":"Lancet Neurol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.bbi.2008.03.009","article-title":"The role of cytokines in the pathophysiology of epilepsy","volume":"22","author":"Vezzani","year":"2008","journal-title":"Brain Behav. Immun."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1111\/j.0013-9580.2003.32803.x","article-title":"Therapy discovery for pharmacoresistant epilepsy and for disease-modifying therapeutics: Summary of the NIH\/NINDS\/AES models II workshop","volume":"44","author":"Stables","year":"2003","journal-title":"Epilepsia"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0920-1211(02)00071-2","article-title":"Kindling: Some old and some new","volume":"50","author":"McIntyre","year":"2002","journal-title":"Epilepsy Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"107155","DOI":"10.1016\/j.eplepsyres.2023.107155","article-title":"Kindling in humans: Does secondary epileptogenesis occur?","volume":"198","author":"Thompson","year":"2023","journal-title":"Epilepsy Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0920-1211(98)00016-3","article-title":"Validation of corneally kindled mice: A sensitive screening model for partial epilepsy in man","volume":"31","author":"Matagne","year":"1998","journal-title":"Epilepsy Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1021\/acschemneuro.1c00782","article-title":"Unraveling the Effects of GSK-3\u03b2 Isoform Modulation against Limbic Seizures and in the 6 Hz Electrical Kindling Model for Epileptogenesis","volume":"13","author":"Aourz","year":"2022","journal-title":"ACS Chem. Neurosci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0920-1211(99)00062-5","article-title":"Corneal kindling in mice: Behavioral and pharmacological differences to conventional kindling","volume":"37","author":"Potschka","year":"1999","journal-title":"Epilepsy Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1007\/s11011-021-00823-3","article-title":"PTZ kindling model for epileptogenesis, refractory epilepsy, and associated comorbidities: Relevance and reliability","volume":"36","author":"Singh","year":"2021","journal-title":"Metab. Brain Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2004.03.009","article-title":"Kindling and status epilepticus models of epilepsy: Rewiring the brain","volume":"73","author":"Morimoto","year":"2004","journal-title":"Prog. Neurobiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.eplepsyres.2016.05.016","article-title":"Fit for purpose application of currently existing animal models in the discovery of novel epilepsy therapies","volume":"126","year":"2016","journal-title":"Epilepsy Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"107735","DOI":"10.1016\/j.neuropharm.2019.107735","article-title":"Biomarkers for epileptogenesis and its treatment","volume":"167","author":"Engel","year":"2020","journal-title":"Neuropharmacology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1684\/epd.2012.0512","article-title":"Is antiepileptogenesis a realistic goal in clinical trials? Concerns and new horizons","volume":"14","author":"Schmidt","year":"2012","journal-title":"Epileptic Disord."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Rubio, C., Romo-Parra, H., L\u00f3pez-Landa, A., and Rubio-Osornio, M. (2024). Classification of Current Experimental Models of Epilepsy. Brain Sci., 14, Erratum in Brain Sci.\u00a02026, 16, 400. https:\/\/doi.org\/10.3390\/brainsci16040400.","DOI":"10.3390\/brainsci16040400"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1177\/15357597241292197","article-title":"Preclinical Testing Strategies for Epilepsy Therapy Development","volume":"25","author":"Riley","year":"2024","journal-title":"Epilepsy Curr."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Mendes, N.F., Pansani, A.P., Carmanh\u00e3es, E.R.F., Tange, P., Meireles, J.V., Ochikubo, M., Chagas, J.R., da Silva, A.V., Monteiro de Castro, G., and Le Sueur-Maluf, L. (2019). The Blood-Brain Barrier Breakdown During Acute Phase of the Pilocarpine Model of Epilepsy Is Dynamic and Time-Dependent. Front. Neurol., 10, Erratum in Front. Neurol.\u00a02019, 10, 603.","DOI":"10.3389\/fneur.2019.00382"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/brain\/awl318","article-title":"Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy","volume":"130","author":"Redeker","year":"2007","journal-title":"Brain"},{"key":"ref_24","unstructured":"Noebels, J.L., Avoli, M., Rogawski, M.A., Vezzani, A., and Delgado-Escueta, A.V. (2026, August 14). Chapter 28. Inflammatory Astrocytic TGF\u03b2 Signaling Induced by Blood\u2013Brain Barrier Dysfunction Drives Epileptogenesis, Jasper\u2019s Basic Mechanisms of the Epilepsies, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK609893\/."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e20190062","DOI":"10.1084\/jem.20190062","article-title":"The blood-brain barrier in health and disease: Important unanswered questions","volume":"217","author":"Profaci","year":"2020","journal-title":"J. Exp. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"7829","DOI":"10.1523\/JNEUROSCI.1751-04.2004","article-title":"Lasting blood-brain barrier disruption induces epileptic focus in the rat somatosensory cortex","volume":"24","author":"Seiffert","year":"2004","journal-title":"J. Neurosci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1535-7511.2007.00190.x","article-title":"Does leakage of the blood-brain barrier mediate epileptogenesis?","volume":"7","author":"Janigro","year":"2007","journal-title":"Epilepsy Curr."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/370341a0","article-title":"Mechanism of activation of the TGF-beta receptor","volume":"370","author":"Wrana","year":"1994","journal-title":"Nature"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1016\/j.jmb.2019.05.022","article-title":"Molecular Engineering of the TGF-\u03b2 Signaling Pathway","volume":"431","author":"Zi","year":"2019","journal-title":"J. Mol. Biol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/epi.16450","article-title":"Repurposed molecules for antiepileptogenesis: Missing an opportunity to prevent epilepsy?","volume":"61","author":"Klein","year":"2020","journal-title":"Epilepsia"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.nbd.2015.02.029","article-title":"Albumin induces excitatory synaptogenesis through astrocytic TGF-\u03b2\/ALK5 signaling in a model of acquired epilepsy following blood-brain barrier dysfunction","volume":"78","author":"Weissberg","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"107742","DOI":"10.1016\/j.neuropharm.2019.107742","article-title":"Inflammation and reactive oxygen species as disease modifiers in epilepsy","volume":"167","author":"Terrone","year":"2020","journal-title":"Neuropharmacology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1528-1167.2007.00988.x","article-title":"Seizure-promoting effect of blood-brain barrier disruption","volume":"48","author":"Marchi","year":"2007","journal-title":"Epilepsia"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"510","DOI":"10.3325\/cmj.2024.65.510","article-title":"New-onset refractory status epilepticus after SARS-CoV-2 infection: A review of literature","volume":"65","author":"Stavropoulos","year":"2024","journal-title":"Croat. Med. J."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"14","DOI":"10.5603\/PJNNS.a2023.0014","article-title":"Blood-brain barrier function in response to SARS-CoV-2 and its spike protein","volume":"57","author":"Suprewicz","year":"2023","journal-title":"Neurol. Neurochir. Pol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"102535","DOI":"10.1016\/j.msard.2020.102535","article-title":"How does the COVID-19 cause seizure and epilepsy in patients? The potential mechanisms","volume":"46","author":"Nikbakht","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1111\/j.1528-1167.2006.00817.x","article-title":"The blood-brain barrier and epilepsy","volume":"47","author":"Oby","year":"2006","journal-title":"Epilepsia"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrneurol.2010.178","article-title":"The role of inflammation in epilepsy","volume":"7","author":"Vezzani","year":"2011","journal-title":"Nat. Rev. Neurol."},{"key":"ref_39","unstructured":"Noebels, J.L., Avoli, M., Rogawski, M.A., Vezzani, A., and Delgado-Escueta, A.V. (2026, August 14). Chapter 30. Neuroinflammation in Epilepsy: Cellular and Molecular Mechanisms, Jasper\u2019s Basic Mechanisms of the Epilepsies, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK609862\/."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"5054","DOI":"10.1523\/JNEUROSCI.19-12-05054.1999","article-title":"Interleukin-1beta immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: Functional evidence for enhancement of electrographic seizures","volume":"19","author":"Vezzani","year":"1999","journal-title":"J. Neurosci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"11534","DOI":"10.1073\/pnas.190206797","article-title":"Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice","volume":"97","author":"Vezzani","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/j.1528-1167.2006.00590.x","article-title":"Inactivation of caspase-1 in rodent brain: A novel anticonvulsive strategy","volume":"47","author":"Ravizza","year":"2006","journal-title":"Epilepsia"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s13311-011-0039-z","article-title":"Interleukin-1\u03b2 biosynthesis inhibition reduces acute seizures and drug resistant chronic epileptic activity in mice","volume":"8","author":"Maroso","year":"2011","journal-title":"Neurotherapeutics"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/nan.12444","article-title":"Review: Neuroinflammatory pathways as treatment targets and biomarker candidates in epilepsy: Emerging evidence from preclinical and clinical studies","volume":"44","author":"Aronica","year":"2018","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuropharm.2014.10.027","article-title":"Neuromodulatory properties of inflammatory cytokines and their impact on neuronal excitability","volume":"96","author":"Vezzani","year":"2015","journal-title":"Neuropharmacology"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1093\/brain\/awn271","article-title":"A novel non-transcriptional pathway mediates the proconvulsive effects of interleukin-1beta","volume":"131","author":"Balosso","year":"2008","journal-title":"Brain"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.bbrc.2008.05.128","article-title":"Inhibition of NMDA-induced outward currents by interleukin-1beta in hippocampal neurons","volume":"372","author":"Zhang","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.nbd.2009.12.028","article-title":"Acute p38-mediated inhibition of NMDA-induced outward currents in hippocampal CA1 neurons by interleukin-1beta","volume":"38","author":"Zhang","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jneuroim.2006.03.001","article-title":"Interleukin-1 beta modulates AMPA receptor expression and phosphorylation in hippocampal neurons","volume":"175","author":"Lai","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejphar.2009.11.060","article-title":"Interleukin-1 receptor antagonist inhibits the release of glutamate, hydroxyl radicals, and prostaglandin E(2) in the hypothalamus during pyrogen-induced fever in rabbits","volume":"629","author":"Huang","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.neuroscience.2013.06.069","article-title":"Interleukin-1\u03b2 alters the sensitivity of cannabinoid CB1 receptors controlling glutamate transmission in the striatum","volume":"250","author":"Motta","year":"2013","journal-title":"Neuroscience"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1046\/j.1460-9568.2000.00140.x","article-title":"Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus","volume":"12","author":"Perego","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.expneurol.2013.05.010","article-title":"The dual role of TNF-\u03b1 and its receptors in seizures","volume":"247","author":"Balosso","year":"2013","journal-title":"Exp. Neurol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.expneurol.2013.01.011","article-title":"Opposing actions of hippocampus TNF\u03b1 receptors on limbic seizure susceptibility","volume":"247","author":"Weinberg","year":"2013","journal-title":"Exp. Neurol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1126\/science.1067859","article-title":"Control of synaptic strength by glial TNFalpha","volume":"295","author":"Beattie","year":"2002","journal-title":"Science"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1523\/JNEUROSCI.5159-07.2008","article-title":"Rapid tumor necrosis factor alpha-induced exocytosis of glutamate receptor 2-lacking AMPA receptors to extrasynaptic plasma membrane potentiates excitotoxicity","volume":"28","author":"Leonoudakis","year":"2008","journal-title":"J. Neurosci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/j.1471-4159.2009.06038.x","article-title":"Tumor necrosis factor-alpha-induced neutral sphingomyelinase-2 modulates synaptic plasticity by controlling the membrane insertion of NMDA receptors","volume":"109","author":"Wheeler","year":"2009","journal-title":"J. Neurochem."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.neuroscience.2009.03.005","article-title":"Molecular and functional interactions between tumor necrosis factor-alpha receptors and the glutamatergic system in the mouse hippocampus: Implications for seizure susceptibility","volume":"161","author":"Balosso","year":"2009","journal-title":"Neuroscience"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1523\/JNEUROSCI.4486-04.2005","article-title":"Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha","volume":"25","author":"Stellwagen","year":"2005","journal-title":"J. Neurosci."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.bbamcr.2016.03.018","article-title":"The role of interleukin-6 signaling in nervous tissue","volume":"1863","author":"Rothaug","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1007\/s13311-020-00893-8","article-title":"IL-6 Receptor Blockade by Tocilizumab Has Anti-absence and Anti-epileptogenic Effects in the WAG\/Rij Rat Model of Absence Epilepsy","volume":"17","author":"Leo","year":"2020","journal-title":"Neurotherapeutics"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/jnr.10635","article-title":"Profound increase in sensitivity to glutamatergic- but not cholinergic agonist-induced seizures in transgenic mice with astrocyte production of IL-6","volume":"73","author":"Samland","year":"2003","journal-title":"J. Neurosci. Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1523\/JNEUROSCI.2830-13.2014","article-title":"Trans-signaling is a dominant mechanism for the pathogenic actions of interleukin-6 in the brain","volume":"34","author":"Campbell","year":"2014","journal-title":"J. Neurosci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nm.2127","article-title":"Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures","volume":"16","author":"Maroso","year":"2010","journal-title":"Nat. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1007\/s13311-019-00815-3","article-title":"HMGB1 Is a Therapeutic Target and Biomarker in Diazepam-Refractory Status Epilepticus with Wide Time Window","volume":"17","author":"Zhao","year":"2020","journal-title":"Neurotherapeutics"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s42494-021-00048-y","article-title":"HMGB1, neuronal excitability and epilepsy","volume":"3","author":"Dai","year":"2021","journal-title":"Acta Epileptol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.bbi.2017.02.002","article-title":"Therapeutic potential of an anti-high mobility group box-1 monoclonal antibody in epilepsy","volume":"64","author":"Zhao","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/s41598-017-01325-y","article-title":"Therapeutic effects of anti-HMGB1 monoclonal antibody on pilocarpine-induced status epilepticus in mice","volume":"7","author":"Fu","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.nbd.2013.03.006","article-title":"Receptor for Advanced Glycation Endproducts is upregulated in temporal lobe epilepsy and contributes to experimental seizures","volume":"58","author":"Iori","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/epi.12461","article-title":"Cyclooxygenase-2 in epilepsy","volume":"55","author":"Rojas","year":"2014","journal-title":"Epilepsia"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0014-4886(02)00019-5","article-title":"Hippocampal kindling epileptogenesis upregulates neuronal cyclooxygenase-2 expression in neocortex","volume":"179","author":"Tu","year":"2003","journal-title":"Exp. Neurol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1528-1167.2010.02889.x","article-title":"Prophylactic, prandial rofecoxib treatment lacks efficacy against acute PTZ-induced seizure generation and kindling acquisition","volume":"52","author":"Claycomb","year":"2011","journal-title":"Epilepsia"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1600-0773.2001.880509.x","article-title":"Nimesulide aggravates kainic acid-induced seizures in the rat","volume":"88","author":"Kunz","year":"2001","journal-title":"Pharmacol. Toxicol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0006-8993(99)01797-7","article-title":"Cyclooxygenase-2 selective inhibitors aggravate kainic acid induced seizure and neuronal cell death in the hippocampus","volume":"843","author":"Baik","year":"1999","journal-title":"Brain Res."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.seizure.2007.05.016","article-title":"Neuroprotective effect of nimesulide, a preferential COX-2 inhibitor, against pentylenetetrazol (PTZ)-induced chemical kindling and associated biochemical parameters in mice","volume":"16","author":"Dhir","year":"2007","journal-title":"Seizure"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S1098-8823(03)00040-6","article-title":"Inducible brain COX-2 facilitates the recurrence of hippocampal seizures in mouse rapid kindling","volume":"71","author":"Takemiya","year":"2003","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.nbd.2006.02.016","article-title":"Cyclooxygenase-2 inhibitor, celecoxib, inhibits the altered hippocampal neurogenesis with attenuation of spontaneous recurrent seizures following pilocarpine-induced status epilepticus","volume":"23","author":"Jung","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.expneurol.2010.03.014","article-title":"The COX-2 inhibitor parecoxib is neuroprotective but not antiepileptogenic in the pilocarpine model of temporal lobe epilepsy","volume":"224","author":"Polascheck","year":"2010","journal-title":"Exp. Neurol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.eplepsyres.2008.12.006","article-title":"Effects of SC58236, a selective COX-2 inhibitor, on epileptogenesis and spontaneous seizures in a rat model for temporal lobe epilepsy","volume":"84","author":"Holtman","year":"2009","journal-title":"Epilepsy Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1073\/pnas.1120195109","article-title":"Small molecule antagonist reveals seizure-induced mediation of neuronal injury by prostaglandin E2 receptor subtype EP2","volume":"109","author":"Jiang","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.eplepsyres.2010.06.012","article-title":"Targeting the prostaglandin E2 EP1 receptor and cyclooxygenase-2 in the amygdala kindling model in mice","volume":"91","author":"Fischborn","year":"2010","journal-title":"Epilepsy Res."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"\u0141ukawski, K., and Czuczwar, S.J. (2023). Oxidative stress and neurodegeneration in animal models of seizures and epilepsy. Antioxidants, 12.","DOI":"10.3390\/antiox12051049"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.bbadis.2019.01.026","article-title":"Excitotoxicity, neuroinflammation and oxidant stress as molecular bases of epileptogenesis and epilepsy-derived neurodegeneration: The role of vitamin E","volume":"1865","author":"Ambrogini","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"107907","DOI":"10.1016\/j.neuropharm.2019.107907","article-title":"Modulating neuroinflammation and oxidative stress to prevent epilepsy and improve outcomes after traumatic brain injury","volume":"172","author":"Eastman","year":"2020","journal-title":"Neuropharmacology"},{"key":"ref_85","unstructured":"Noebels, J.L., Avoli, M., Rogawski, M.A., Vezzani, A., and Delgado-Escueta, A.V. (2026, August 14). Chapter 31. Role of Reactive Oxygen Species in Epilepsy, Jasper\u2019s Basic Mechanisms of the Epilepsies, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK609820\/."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2174\/157015912804499447","article-title":"The role of reactive species in epileptogenesis and influence of antiepileptic drug therapy on oxidative stress","volume":"10","author":"Martinc","year":"2012","journal-title":"Curr. Neuropharmacol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.yebeh.2018.09.027","article-title":"Long-term monotherapy treatment with vitamin E reduces oxidative stress, but not seizure frequency in rats submitted to the pilocarpine model of epilepsy","volume":"88","author":"Pansani","year":"2018","journal-title":"Epilepsy Behav."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"106410","DOI":"10.1016\/j.yebeh.2019.07.011","article-title":"Reactive oxygen species in status epilepticus","volume":"101","author":"Kovac","year":"2019","journal-title":"Epilepsy Behav."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pbb.2007.10.007","article-title":"Neuroprotective actions of vitamin C related to decreased lipid peroxidation and increased catalase activity in adult rats after pilocarpine-induced seizures","volume":"89","author":"Santos","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_90","first-page":"103","article-title":"Effect of intracerebroventricular administration of ascorbic acid on a seizure model induced by pentylenetetrazol in male rats","volume":"22","author":"Kamalimanesh","year":"2018","journal-title":"Physiol. Pharmacol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.neuroscience.2015.07.005","article-title":"Status epilepticus results in persistent overproduction of reactive oxygen species, inhibition of which is neuroprotective","volume":"303","author":"Williams","year":"2015","journal-title":"Neuroscience"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1111\/j.1471-4159.2006.04019.x","article-title":"Neuronal sensitivity to kainic acid is dependent on the Nrf2-mediated actions of the antioxidant response element","volume":"98","author":"Kraft","year":"2006","journal-title":"J. Neurochem."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"4084","DOI":"10.1039\/C7RA11491E","article-title":"\u03b1-Lipoic acid alleviates pentetrazol-induced neurological deficits and behavioral dysfunction in rats with seizures via an Nrf2 pathway","volume":"8","author":"Cheng","year":"2018","journal-title":"RSC Adv."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s42494-025-00228-0","article-title":"From the different pathogenesis of epileptogenesis: Vitamins as an adjunctive treatment for epilepsy","volume":"7","author":"Sun","year":"2025","journal-title":"Acta Epileptol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1528-1167.2010.02606.x","article-title":"Inflammation induced by LPS enhances epileptogenesis in immature rat and may be partially reversed by IL1RA","volume":"51","author":"Auvin","year":"2010","journal-title":"Epilepsia"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.nbd.2008.05.007","article-title":"Interleukin Converting Enzyme inhibition impairs kindling epileptogenesis in rats by blocking astrocytic IL-1beta production","volume":"31","author":"Ravizza","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.nbd.2016.12.007","article-title":"Blockade of the IL-1R1\/TLR4 pathway mediates disease-modification therapeutic effects in a model of acquired epilepsy","volume":"99","author":"Iori","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1080\/1028415X.2016.1189057","article-title":"Resveratrol suppressed seizures by attenuating IL-1\u03b2, IL1-Ra, IL-6, and TNF-\u03b1 in the hippocampus and cortex of kindled mice","volume":"20","author":"Hoda","year":"2017","journal-title":"Nutr. Neurosci."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.yebeh.2013.06.007","article-title":"Possible nitric oxide mechanism in the protective effect of hesperidin against pentylenetetrazole (PTZ)-induced kindling and associated cognitive dysfunction in mice","volume":"29","author":"Kumar","year":"2013","journal-title":"Epilepsy Behav."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.brainres.2014.05.017","article-title":"3-Methyl-1-phenyl-2-pyrazolin-5-one or N-acetylcysteine prevents hippocampal mossy fiber sprouting and rectifies subsequent convulsive susceptibility in a rat model of kainic acid-induced seizure ceased by pentobarbital","volume":"1590","author":"Nomura","year":"2014","journal-title":"Brain Res."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.pharep.2016.07.005","article-title":"Neuroprotective mechanism of Coenzyme Q10 (CoQ10) against PTZ induced kindling and associated cognitive dysfunction: Possible role of microglia inhibition","volume":"68","author":"Bhardwaj","year":"2016","journal-title":"Pharmacol. Rep."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.lfs.2010.09.006","article-title":"Protective effect of curcumin against seizures and cognitive impairment in a pentylenetetrazole-kindled epileptic rat model","volume":"87","author":"Mehla","year":"2010","journal-title":"Life Sci."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.eplepsyres.2018.02.011","article-title":"Neuroprotective effect of Nrf2 activator dimethyl fumarate, on the hippocampal neurons in chemical kindling model in rat","volume":"143","author":"Singh","year":"2018","journal-title":"Epilepsy Res."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1093\/brain\/awz130","article-title":"Targeting oxidative stress improves disease outcomes in a rat model of acquired epilepsy","volume":"142","author":"Pauletti","year":"2019","journal-title":"Brain"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1093\/brain\/awy071","article-title":"KEAP1 inhibition is neuroprotective and suppresses the development of epilepsy","volume":"141","author":"Eckel","year":"2018","journal-title":"Brain"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/ana.24147","article-title":"Losartan prevents acquired epilepsy via TGF-signaling suppression","volume":"75","author":"Cacheaux","year":"2014","journal-title":"Ann. Neurol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"8927","DOI":"10.1523\/JNEUROSCI.0430-09.2009","article-title":"Transcriptome profiling reveals TGF-beta signaling involvement in epileptogenesis","volume":"29","author":"Cacheaux","year":"2009","journal-title":"J. Neurosci."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.brainres.2018.05.027","article-title":"The angiotensin II type I receptor antagonist losartan retards amygdala kindling-induced epileptogenesis","volume":"1694","author":"Nozaki","year":"2018","journal-title":"Brain Res."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.pbb.2014.10.005","article-title":"Antiepileptogenic and neuroprotective effects of losartan in kainate model of temporal lobe epilepsy","volume":"127","author":"Tchekalarova","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"106285","DOI":"10.1016\/j.yebeh.2019.04.038","article-title":"Blood-brain barrier dysfunction in status epilepticus: Mechanisms and role in epileptogenesis","volume":"101","author":"Swissa","year":"2019","journal-title":"Epilepsy Behav."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1042\/CS20240771","article-title":"Candesartan restores blood-brain barrier dysfunction, mitigates aberrant gene expression, and extends lifespan in a knockin mouse model of epileptogenesis","volume":"138","author":"Hammer","year":"2024","journal-title":"Clin. Sci."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1001\/jamaneurol.2024.1714","article-title":"Angiotensin receptor blockers for hypertension and risk of epilepsy","volume":"81","author":"Wen","year":"2024","journal-title":"JAMA Neurol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.phrs.2012.10.006","article-title":"What is behind the non-antibiotic properties of minocycline?","volume":"67","author":"Zarzuelo","year":"2013","journal-title":"Pharmacol. Res."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.bbr.2008.09.040","article-title":"Minocycline and neurodegenerative diseases","volume":"196","author":"Kim","year":"2009","journal-title":"Behav. Brain Res."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.neuroscience.2014.12.021","article-title":"Minocycline inhibits brain inflammation and attenuates spontaneous recurrent seizures following pilocarpine-induced status epilepticus","volume":"87","author":"Wang","year":"2015","journal-title":"Neuroscience"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejphar.2015.12.002","article-title":"Minocycline fails to exert antiepileptogenic effects in a rat status epilepticus model","volume":"771","author":"Russmann","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"124193","DOI":"10.1016\/j.lfs.2026.124193","article-title":"Minocycline-induced microglial remodeling restores hippocampal NMDA-dependent synaptic plasticity and reduces anxiety-like behavior in juvenile rats with temporal lobe epileptogenesis","volume":"388","author":"Postnikova","year":"2026","journal-title":"Life Sci."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1111\/epi.12246","article-title":"High\u2013dose rapamycin blocks mossy fiber sprouting but not seizures in a mouse model of temporal lobe epilepsy","volume":"54","author":"Heng","year":"2013","journal-title":"Epilepsia"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1523\/JNEUROSCI.4852-10.2011","article-title":"Rapamycin suppresses mossy fiber sprouting but not seizure frequency in a mouse model of temporal lobe epilepsy","volume":"31","author":"Buckmaster","year":"2011","journal-title":"J. Neurosci."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.neulet.2011.12.051","article-title":"Post-treatment with rapamycin does not prevent epileptogenesis in the amygdala stimulation model of temporal lobe epilepsy","volume":"509","author":"Sliwa","year":"2012","journal-title":"Neurosci. Lett."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/ejn.12835","article-title":"Activation of mTOR signaling pathway is secondary to neuronal excitability in a mouse model of mesio-temporal lobe epilepsy","volume":"41","author":"Shima","year":"2015","journal-title":"Eur. J. Neurosci."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/epi.13345","article-title":"Effects of rapamycin and curcumin treatment on the development of epilepsy after electrically induced status epilepticus in rats","volume":"57","author":"Drion","year":"2016","journal-title":"Epilepsia"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/j.1528-1167.2012.03513.x","article-title":"Inhibition of mammalian target of rapamycin reduces epileptogenesis and blood-brain barrier leakage but not microglia activation","volume":"53","author":"Forte","year":"2012","journal-title":"Epilepsia"},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Guo, D., Zeng, L., Brody, D.L., and Wong, M. (2013). Rapamycin attenuates the development of posttraumatic epilepsy in a mouse model of traumatic brain injury. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0064078"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.cellsig.2016.02.008","article-title":"Inhibition of mTOR by apigenin in UVB-irradiated keratinocytes: A new implication of skin cancer prevention","volume":"28","author":"Bridgeman","year":"2016","journal-title":"Cell Signal."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00221-023-06557-1","article-title":"Investigating the mechanism of antiepileptogenic effect of apigenin in kainate temporal lobe epilepsy: Possible role of mTOR","volume":"241","author":"Nikbakht","year":"2023","journal-title":"Exp. Brain Res."},{"key":"ref_128","first-page":"561","article-title":"Neuroprotective properties of statins","volume":"57","author":"Stepien","year":"2005","journal-title":"Pharmacol. Rep."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jacl.2011.06.007","article-title":"Statins and their influence on brain cholesterol","volume":"5","author":"Cibickova","year":"2011","journal-title":"J. Clin. Lipidol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1001\/archneurol.2010.199","article-title":"3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in the treatment of central nervous system diseases","volume":"67","author":"Willey","year":"2010","journal-title":"Arch. Neurol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.pharep.2014.02.026","article-title":"Statins\u2014Are they anticonvulsant?","volume":"66","author":"Banach","year":"2014","journal-title":"Pharmacol. Rep."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ejphar.2011.10.030","article-title":"The interactions of atorvastatin and fluvastatin with carbamazepine, phenytoin and valproate in the mouse maximal electroshock seizure model","volume":"674","author":"Stepien","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"174290","DOI":"10.1016\/j.ejphar.2021.174290","article-title":"Effect of acute and chronic exposure to lovastatin on the anticonvulsant action of classical antiepileptic drugs in the mouse maximal electroshock-induced seizure model","volume":"907","author":"Tomaszewski","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1111\/epi.17303","article-title":"Statins as antiepileptogenic drugs: Analyzing the evidence and identifying the most promising statin","volume":"63","author":"Hufthy","year":"2022","journal-title":"Epilepsia"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.pharep.2017.08.016","article-title":"Subtle improvement of seizure susceptibility by atorvastatin treatment during epileptogenesis","volume":"70","author":"Oliveira","year":"2018","journal-title":"Pharmacol. Rep."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.yebeh.2017.10.021","article-title":"Effect of atorvastatin on behavioral alterations and neuroinflammation during epileptogenesis","volume":"78","author":"Oliveira","year":"2018","journal-title":"Epilepsy Behav."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.yebeh.2014.04.009","article-title":"Lovastatin decreases the synthesis of inflammatory mediators during epileptogenesis in the hippocampus of rats submitted to pilocarpine-induced epilepsy","volume":"36","author":"Gouveia","year":"2014","journal-title":"Epilepsy Behav."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/epi.12686","article-title":"Protective effects of some statins on epileptogenesis and depressive-like behavior in WAG\/Rij rats, a genetic animal model of absence epilepsy","volume":"55","author":"Citraro","year":"2014","journal-title":"Epilepsia"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/j.1528-1167.2011.03073.x","article-title":"Atorvastatin treatment during epileptogenesis in a rat model for temporal lobe epilepsy","volume":"52","author":"Holtman","year":"2011","journal-title":"Epilepsia"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"106024","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.106024","article-title":"Statins for the prevention of post-stroke seizure and epilepsy development: A systematic review and meta-analysis","volume":"30","author":"Acton","year":"2021","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jocn.2020.11.023","article-title":"Statin on post-stroke epilepsy: A systematic review and meta-analysis","volume":"83","author":"Fang","year":"2021","journal-title":"J. Clin. Neurosci."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/epi.18174","article-title":"Role of cholesterol in modulating brain hyperexcitability","volume":"66","author":"Wheeles","year":"2025","journal-title":"Epilepsia"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s10020-024-01025-0","article-title":"The pleiotropic effects of statins: A comprehensive exploration of neurovascular unit modulation and blood-brain barrier protection","volume":"30","author":"Liu","year":"2024","journal-title":"Mol. Med."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s43440-024-00603-7","article-title":"Presynaptic antiseizure medications\u2014Basic mechanisms and clues for their rational combinations","volume":"76","author":"Czuczwar","year":"2024","journal-title":"Pharmacol. Rep."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.brainres.2010.06.061","article-title":"Levetiracetam suppresses development of spontaneous EEG seizures and aberrant neurogenesis following kainate-induced status epilepticus","volume":"1352","author":"Sugaya","year":"2010","journal-title":"Brain Res."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.brainres.2015.03.005","article-title":"Prevention of status pilepticus-induced brain edema and neuronal cell loss by repeated treatment with high-dose levetiracetam","volume":"1608","author":"Itoh","year":"2015","journal-title":"Brain Res."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"106994","DOI":"10.1016\/j.eplepsyres.2022.106994","article-title":"Anti-epileptogenic effects of synaptic vesicle protein 2A modulation in a mouse model of Alzheimer\u2019s disease","volume":"186","author":"Silva","year":"2022","journal-title":"Epilepsy Res."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"113571","DOI":"10.1016\/j.expneurol.2020.113571","article-title":"Early intervention with levetiracetam prevents the development of cortical hyperexcitability and spontaneous epileptiform activity in two models of neurotrauma in rats","volume":"337","author":"Yang","year":"2021","journal-title":"Exp. Neurol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/epi.17167","article-title":"Brivaracetam prevents the development of epileptiform activity when administered early after cortical neurotrauma in rats","volume":"63","author":"Ling","year":"2022","journal-title":"Epilepsia"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"107217","DOI":"10.1016\/j.eplepsyres.2023.107217","article-title":"4-AP challenge reveals that early intervention with brivaracetam prevents posttraumatic eepileptogenesis in rats","volume":"196","author":"Michelson","year":"2023","journal-title":"Epilepsy Res."},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Miziak, B., Konarzewska, A., U\u0142amek-Kozio\u0142, M., Dudra-Jastrzebska, M., Pluta, R., and Czuczwar, S.J. (2020). Anti-epileptogenic effects of antiepileptic drugs in epilepsy. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21072340"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"136574","DOI":"10.1016\/j.neulet.2022.136574","article-title":"Effects of in utero exposure to valproate or levetiracetam on the seizures and newborn histopathology of genetic absence epilepsy rats","volume":"776","author":"Kantarci","year":"2022","journal-title":"Neurosci. Lett."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"137477","DOI":"10.1016\/j.neulet.2023.137477","article-title":"Effect of U50488, a selective kappa opioid receptor agonist and levetiracetam against lithium-pilocarpine-induced status epilepticus, spontaneous convulsive seizures and related cognitive impairment","volume":"815","author":"Kumar","year":"2023","journal-title":"Neurosci. Lett."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"104949","DOI":"10.1016\/j.nbd.2020.104949","article-title":"Prolonged prophylactic effects of gabapentin on status epilepticus-induced neocortical injury","volume":"142","author":"Gu","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Rossi, A., Murta, V., Auzmendi, J., and Ramos, A.J. (2017). Early gabapentin treatment during the latency period increases convulsive threshold, reduces microglial activation and macrophage infiltration in the lithium-pilocarpine model of epilepsy. Pharmaceuticals, 10.","DOI":"10.3390\/ph10040093"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"108802","DOI":"10.1016\/j.yebeh.2022.108802","article-title":"The anticonvulsant effect of chronic treatment with topiramate after pilocarpine-induced status epilepticus is accompanied by a suppression of comorbid behavioral impairments and robust neuroprotection in limbic regions in rats","volume":"134","author":"Atanasova","year":"2022","journal-title":"Epilepsy Behav."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.eplepsyres.2019.02.010","article-title":"Network pharmacology for antiepileptogenesis: Tolerability and neuroprotective effects of novel multitargeted combination treatments in nonepileptic vs. post-status epilepticus mice","volume":"151","author":"Welzel","year":"2019","journal-title":"Epilepsy Res."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"105227","DOI":"10.1016\/j.nbd.2020.105227","article-title":"Systematic evaluation of rationally chosen multitargeted drug combinations: A combination of low doses of levetiracetam, atorvastatin and ceftriaxone exerts antiepileptogenic effects in a mouse model of acquired epilepsy","volume":"149","author":"Welzel","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Pawlik, M.J., Miziak, B., Walczak, A., Konarzewska, A., Chro\u015bci\u0144ska-Krawczyk, M., Albrecht, J., and Czuczwar, S.J. (2021). Selected molecular targets for antiepileptogenesis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22189737"},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Za\u0142uska-Ogryzek, K., Marz\u0119da, P., Wr\u00f3blewska-\u0141uczka, P., Florek-\u0141uszczki, M., Plewa, Z., Bojar, H., Zolkowska, D., and \u0141uszczki, J.J. (2021). Interactions among lacosamide and second-generation antiepileptic drugs in the tonic-clonic seizure model in mice. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22115537"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/17512433.2018.1500895","article-title":"A viewpoint on rational and irrational fixed-drug combinations","volume":"11","author":"Miziak","year":"2018","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/epi.12299","article-title":"Epilepsy biomarkers","volume":"54","author":"Engel","year":"2013","journal-title":"Epilepsia"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1001\/archneur.57.11.1617","article-title":"Seizures after stroke: A prospective multicenter study","volume":"57","author":"Bladin","year":"2000","journal-title":"Arch. Neurol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4103\/2152-7806.149613","article-title":"Anti-epileptic prophylaxis in traumatic brain injury: A retrospective analysis of patients undergoing craniotomy versus decompressive craniectomy","volume":"6","author":"Ramakrishnan","year":"2015","journal-title":"Surg. Neurol. Int."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.neuroscience.2025.01.057","article-title":"Clinical significance of GABA, NSE, and miR-155 expression in patients with post-stroke epilepsy","volume":"571","author":"Wang","year":"2025","journal-title":"Neuroscience"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.seizure.2026.01.004","article-title":"Association of systemic inflammatory markers with post-stroke epilepsy after ischemic stroke: A competing risk analysis","volume":"135","author":"Imemkamon","year":"2026","journal-title":"Seizure"},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"He, W., Xu, M., Lin, R., Wang, S., Huang, W., Chen, H., Yang, Y., and Lin, J. (2025). Novel prognostic score based on the monocyte-to-lymphocyte ratio and CAVE score for epilepsy after primary intracerebral hemorrhage. BMC Neurol., 26.","DOI":"10.1186\/s12883-025-04562-1"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s42494-025-00226-2","article-title":"Predictive value of peripheral blood inflammatory markers for epilepsy occurrence in traumatic brain injury patients","volume":"7","author":"Wang","year":"2025","journal-title":"Acta Epileptol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1720112","DOI":"10.3389\/fneur.2025.1720112","article-title":"Inflammatory proteins as acute biomarkers of post-traumatic epilepsy","volume":"16","author":"Balosso","year":"2025","journal-title":"Front Neurol."},{"key":"ref_170","doi-asserted-by":"crossref","unstructured":"Chen, F., He, X., Luan, G., and Li, T. (2019). Role of DNA methylation and adenosine in ketogenic diet for pharmacoresistant epilepsy: Focus on epileptogenesis and associated comorbidities. Front. Neurol., 10.","DOI":"10.3389\/fneur.2019.00119"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"2567677","DOI":"10.1080\/29933935.2025.2567677","article-title":"A novel ketogenic diet that reduces seizures and prevents liver steatosis leads to related gut microbiome changes and restores cecal short-chain fatty acid levels in the rapid kindling rat model of epileptogenesis","volume":"2","author":"Meeusen","year":"2025","journal-title":"Gut Microbes Rep."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s00018-023-04988-1","article-title":"Low glycemic index diet restrains epileptogenesis in a gender specific fashion","volume":"80","author":"Michetti","year":"2023","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1111\/epi.18394","article-title":"Clinical trials of prevetion of acquired epilepsy: New proof-of-concept approach to restart trials","volume":"66","author":"Klein","year":"2025","journal-title":"Epilepsia"}],"container-title":["Current Issues in Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1467-3045\/48\/8\/842\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T04:26:06Z","timestamp":1787286366000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1467-3045\/48\/8\/842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,19]]},"references-count":173,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["cimb48080842"],"URL":"https:\/\/doi.org\/10.3390\/cimb48080842","relation":{},"ISSN":["1467-3045"],"issn-type":[{"value":"1467-3045","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,19]]}}}